Investors in need of a lift Earnings season is off to a rocky start and not only are investors not comforted by what they’re seeing, but...
Pfizer Inc. (NYSE: PFE) has gained 42.2% in the past six months. This is because of some of its breakthrough projects, including receiving approval from the...
Twenty-seven drug makers have signed onto a deal to manufacture a generic version of molnupiravir, Merck’s oral antiviral The post 27 drugmakers to provide generic COVID...
Gasoline prices are the highest they've been in a decade as demand outpaces supply of crude.
Pfizer released data from several studies showing that nirmatrelvir, the active main protease inhibitor of the company's antiviral combination therapy Paxlovid (nirmatrelvir/ritonavir), is effective against the...
Having exhausted policy tools to convince vaccination holdouts to change their minds, it seems little can be gained from additional vaccine mandates than further weakening social...
Could these biotech stocks be poised for gains in 2022? The post 5 Top Biotech Stocks To Watch In January 2022 appeared first on Stock Market...
The economy doesn’t have a real inflation problem, and not recognising the difference is the biggest danger.
Futures Slide After Disappointing JPMorgan Earnings, Tech Rout Worsens After trading flat for much of the overnight session, S&P futures slumped to session lows shortly after...
Click here to read the previous cleantech outlook.For the past few years, the cleantech sector has been gathering interest from investors as the world turns to...
PBOC's Soft Dollar Peg to Help Yuan Basket Fall By Ye Xie, Bloomberg Markets Live reporter and commentator The PBOC has managed to keep the dollar-yuan...
Which penny stocks are on your watchlist right now? The post Here Are 3 Penny Stocks You Need to Know About in January appeared first on...
Powell testimony soothes markets Federal Reserve Chairman Jerome Powell, testifying at his confirmation hearing on the Hill, soothed markets overnight in a performance worthy of Goldilocks...
Consumer spending on mobile apps reached $170 billion in 2021, according to App Annie’s newly released “State of Mobile 2022″ report, out today, which offers a...
Click here to read the previous rare earths outlook.Following an uncertain 2020 on the back of the COVID-19 pandemic, the rare earth market continued to see...
Damian Washington didn’t want to be “the MS guy.” He was a lifelong performer — he booked his first commercial at 15 promoting Captain Crunch cereal...
A Pennsylvania CDMO specializing in cell and gene therapy manufacturing is receiving a big influx of cash from a South Korean drugmaker — and it has...
Asian markets mixed Wall Street had a schizophrenic session overnight, falling hard for most of the day as markets continued winding themselves up that the Federal...
Does the U.S. produce enough solar energy to power your coffee machine?
Beijing Expected To Keep 'Zero COVID' Policy For At Least Another Year With China facing the prospect of an omicron-driven wave of COVID cases that's worse...
Pfizer Inc (NYSE: PFE), Moderna Inc (NASDAQ: MRNA) and Johnson & Johnson (NYSE: JNJ) booster dose of the vaccine against coronavirus is administered. Those above 18...
Supply chain disruptions have become a major challenge for the global economy since the start of the COVID-19 pandemic. Factory shutdowns (particularly in Asia) and widespread...
International relations, elections, climate change policies and the continuing pandemic are some of the political events to keep an eye out for in the upcoming year.
Tech stocks have been a dominant theme, will it continue in 2022? The post Best Stocks To Invest In 2022? 4 Tech Stocks For Your Watchlist...
Check out these biotech stocks gaining investor interest now. The post 3 Biotech Stocks To Watch In 2022 appeared first on Stock Market News, Quotes, Charts...
World Reports Record 1.3 Million New COVID Cases As US Outbreak Flares On the last day of the year, the COVID pandemic is ending 2021 with...
Futures Rise, Eye 71st All-Time High After closing at a fresh all time high on Wednesday, its 70th high for the year, which is the most...
Researchers at Emory investigated the use of an FDA-approved ADHD medication on patients with mild Alzheimer’s symptoms and found it appeared to reduce levels of tau.
Protests Erupt In South Korea Over Vaccination Deaths Americans and Europeans aren't the only people to express skepticism of the COVID jabs produced by a handful...
Misinformation will continue to strain society in 2022 as the lines between misinformation and political speech blur, cynicism grows and the lack of regulation allows misinformation...